|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: PACIFIC AMERICAN INCOME SHARES INC, NSAR-A, EX-27, 2000-08-16 |
Next: PFIZER INC, 8-K, EX-99, 2000-08-16 |
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE Date of report: August 16, 2000 Date of earliest event reported: June 19, 2000
PFIZER INC. (Exact name of registrant as specified in its charter) |
|
DELAWARE |
1-3619 |
13-5315170 |
|
235 East 42nd Street, New York, New York 10017 (212) 573-2323 |
Item 5. Other Events
As previously reported in the registrant's Form 8-K dated June 20, 2000, a subsidiary of Pfizer Inc. ("Pfizer" or the "Company") and Warner-Lambert Company ("Warner-Lambert") completed their merger whereby Warner-Lambert became a wholly owned subsidiary of Pfizer. The Company is filing an unaudited condensed consolidated statement of income for the one month ended July 30, 2000 and the seven months ended July 30, 2000 which reflects at least 30 days of post-merger operating results fo s included in Exhibit 99 to this Form 8-K and is incorporated by reference.
Item 7(c). Exhibits
|
99 |
Unaudited condensed consolidated statement of income for the one month and seven months ended July 30, 2000. |
SIGNATURE
Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.
|
PFIZER INC. |
|
|
Dated: August 16, 2000 |
By: /s/ Margaret M. Foran
|
Index to Exhibits
|
Number |
Description |
|
99 |
Unaudited condensed consolidated statement of income for the one month and seven months ended July 30, 2000. |
|
|